Leana Wen
Known title: DirectorCIK: 0001847598
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
UroGen Pharma highlighted as emerging GARP stock. UroGen Pharma is being discussed as an emerging GARP stock, indicating growing interest from analysts. The average target price of $60.00, with a range of $48.00 to $75.00, suggests potential upside from its current level. The stock trades near its 12‑touch support at $40.15 and has a moderate RSI of 35.3, indicating it is not overbought. These factors may influence how investors view its future performance.
Transaction History
| GKOS | ▼ Sell | Open Market | 525 | $88K | 7/31/2026 | View on chart |
| GKOS | ▲ Buy | Grant | 1,878 | $0 | 5/28/2026 | View on chart |
| GKOS | ▼ Sell | Open Market | 1,700 | $244K | 5/1/2026 | View on chart |
| GKOS | ▲ Buy | Grant | 623 | $0 | 1/2/2026 | View on chart |
| URGN | ▲ Buy | Option Exercise | 2,000 | — | 11/26/2025 | View on chart |
| GKOS | ▲ Buy | Grant | 2,108 | $0 | 5/29/2025 | View on chart |
| GKOS | ▲ Buy | Grant | 461 | $0 | 1/2/2025 | View on chart |
| GKOS | ▲ Buy | Grant | 1,716 | $0 | 5/30/2024 | View on chart |
| GKOS | ▲ Buy | Grant | 3,230 | $0 | 6/1/2023 | View on chart |
| GKOS | ▲ Buy | Grant | 1,572 | $0 | 1/3/2023 | View on chart |
| GKOS | ▲ Buy | Grant | 1,572 | $0 | 1/3/2023 | View on chart |
| GKOS | ▲ Buy | Grant | 4,364 | $0 | 6/2/2022 | View on chart |
| GKOS | ▲ Buy | Grant | 1,455 | $0 | 1/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
GKOS Joins Big Stocks Rising on Wednesday; 10‑Year Gains Highlight
GKOS was among the large stocks that gained on Wednesday, adding to its recent upward momentum. A Benzinga piece noted that a $1,000 investment in GKOS 10 years ago would be worth a substantial amount today, underscoring the company's long‑term growth. These stories highlight both the current price action and the company's historical performance.
GKOS Joins Big Stocks Rising on Wednesday; 10‑Year Gains Highlight. GKOS was among the large stocks that gained on Wednesday, adding to its recent upward momentum. A Benzinga piece noted that a $1,000 investment in GKOS 10 years ago would be worth a substantial amount today, underscoring the company's long‑term growth. These stories highlight both the current price action and the company's historical performance.